Omeros (OMER) Current Taxes (2021 - 2026)

Omeros (OMER) reported Current Taxes of $1.1 million for Q1 2026, little changed sequentially from $1.1 million in Q4 2025.

Omeros (OMER) Current Taxes (2021 - 2026) Analysis & Trends

Omeros (OMER) has 6 years of Current Taxes data on file, last reported at $1.1 million in Q1 2026.

For the quarter ending Q1 2026, Current Taxes changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $1.1 million, up 1983.64% from the prior year.
Current Taxes was little changed at $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
In the past five years, Current Taxes ranged from a high of $4.9 million in Q4 2022 to a low of $55000.0 in Q4 2024.
A 5-year average of $2.1 million and a median of $1.2 million in 2023 frame the typical range for Current Taxes.
Across the five-year window, Current Taxes jumped 1341.12% in 2022 and jumped 1983.64% in 2025, its largest moves.
Tracing OMER's Current Taxes over 5 years: stood at $4.9 million in 2022, then sank by 74.79% to $1.2 million in 2023, then slumped by 95.52% to $55000.0 in 2024, then jumped by 1983.64% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
Business Quant data shows OMER's Current Taxes at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $55000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	63.52 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	49.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Omeros	739.31 Mn	739.31 Mn	9.31 Mn	1.15 Mn

Download Data